Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

DNI Metals | Status on Trading, Fraud Trial, and Permits

DNI Metals (CSE: DNI | OTC: DMNKF) Dan Wei r of DNI Metals sits down with Maurice Jackson of Proven and Probable to provide shareholders updates on when trading will commence on the Canadian Stock Exchange, judicial ma...

'Well-Planned, Accretive Acquisition' of Leagold Moves Equinox to Mid-Tier Status

The highlights and benefits of the transaction are provided in a Haywood report. In a Dec. 17 research note, Haywood analyst Kerry Smith purported that Equinox Gold Corp.'s (EQX:TSX.V) acquisition of Leagold Mining is "a good transaction at a good price" and recomme...

'Undervalued' Biopharma Gets Breakthrough Status for Alzheimer's Agitation Drug

Axsome Therapeutics' latest news and clinical outlook are discussed in an H.C. Wainwright & Co. report. In a June 30 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that the U.S. Food and Drug Administration (FDA) designated Axsome Therapeutics...

Kiniksa Pharma Awarded FDA Breakthrough Therapy Status for Pericarditis Treatment Drug

Shares of Kiniksa Pharmaceuticals opened nearly 30% higher today after the firm reported that the FDA granted Breakthrough Therapy designation for Rilonacept for the treatment of recurrent pericarditis. This morning, Hamilton, Bermuda based biopharmaceutical company ...

Savara Shares Double After FDA Grants Breakthrough Therapy Status for aPAP Treatment

Shares of Savara opened nearly 140% higher today after the orphan lung disease company advised that the FDA has granted Breakthrough Therapy designation for the firm's Molgradex for treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP). This morning orphan lun...

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...

Analyst: Gold Explorer Warrants Top Pick Status

The rationale for this view of the company is provided in an Echelon Wealth Partners report. In an Oct. 3 research note, analyst Gabriel Gonzalez reported that Echelon Wealth Partners continues to consider Revival Gold Inc. (RVG:TSX.V) a Top Pick, as the company's 2...

Rover Metals | On the Cusp of Something Big?

https://www.streetwisereports.com/article/2019/11/20/junior-minor-cultivates-markets-and-projects-for-growth.html Rover Metals (TSX.V: ROVR | OTCQB: ROVMF ) Judson Culter the CEO and Director of Rover Metals sits down...

Tapping Into a Legendary Mine

A legendary historical mine is one thing, but one that can be resurrected and brought back into the current market is another thing entirely. It takes a strong market and many of the right circumstances for a massive project with known, historical, and even "legendary" s...

Gold Explorer Advancing Two Canadian Properties, Benefiting from New Brunswick Protection Status ...

Gold Explorer Advancing Two Canadian Properties, Benefiting from New Brunswick Protection Status of Mining Claims X-Terra Resources has the funding to simultaneously explore two of its properties. X-Terra Resources Inc.'s (XTT:TSX; XTR:FSE) gold...
1 2 3 4 5 6 7 8 9 10 ...